Vertex Pharmaceuticals’ suzetrigine approved for FDA review: A breakthrough in pain management
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced a pivotal advancement in the treatment of acute pain. The U.S. Food and Drug Administration (FDA) has officially accepted the New Drug Application (NDA) for suzetrigine, marking a significant step toward introducing a new class of pain medication. This development could transform the management of moderate-to-severe acute pain, […]